The Riluzole Derivative 2-Amino-6-trifluoromethylthiobenzothiazole (SKA-19), a Mixed KCa2 Activator and NaV Blocker, is a Potent Novel Anticonvulsant

Coleman N1, Nguyen HM, Cao Z, Brown BM, Jenkins DP, Zolkowska D, Chen YJ, Tanaka BS, Goldin AL, Rogawski MA, Pessah IN, Wulff H
Neurotherapeutics. 2014 Sep 26. [Epub ahead of print]
PubMed PMID: